Search results
The principles of biomedical ethics--beneficence and nonmaleficence, respect for autonomy, and justice--can help to guide cannabis care. To uphold the principles of beneficence and nonmaleficence, providers should recommend cannabis only for conditions where the evidence base is well-established.
The main objection to the medical use of marijuana by the federal government is largely attributable today to a national policy of zero-tolerance toward illicit drugs. This objection is extended to include a prohibition on legalizing marijuana for medical purposes as well, and is underscored by three suppositions initially outlined during the ...
An ethical objection to recommendation of medical marijuana use but not attestation of a qualifying condition may hinge on what the physician perceives to be their degree of involvement, and thus, moral culpability, in a patient's immoral action.
24 paź 2020 · If cannabis or its constituents are legalized in any state or jurisdiction, this policy statement proposes action steps to foster planned and consistent protection of health as well as governance through regulation and monitoring of the commercial legal cannabis market.
22 sty 2022 · As of 2021, 36 states and four territories approved the legalization of medical cannabis via medical marijuana laws (MMLs), and 15 states and District of Columbia (DC) have adopted recreational marijuana laws (RMLs).
1 lut 2022 · Following this, in 2001, Canada implemented the Marihuana Medical Access Regulations (MMAR), through which the government of Canada, provided patients with debilitating illnesses with an Authorization to Possess (ATP) medical cannabis under the recommendation of a physician, and a Personal or a Designated Production License (PPL/DPL) to produce ...
1 mar 2018 · The increasing use of medical cannabis (MC) in the past decade raises several ethical considerations for the clinician. Regulatory issues stem from a gap between MC registration and certification in each country.
